1. Tipton KF (1989) Monoamine oxidase inhibitors as antidepressants. In: Tipton KF, Youdim MBH (eds) Biochemical and pharmacological aspects of depression. Taylor & Francis, London, pp 1–24
2. Patek DR, Hellerman L (1974) Mitochondrial monoamine oxidase: mechanism of inhibition by phenylhydrazine and aralkylhydrazine. Role of enzymatic oxidation. J Biol Chem 249:2373–2380
3. Kenny WC, Nagy J, Salach JI, Singer TP (1979). Structure of the covalent phenylhydrazine adduct of monoamine oxidase. In: Singer TP, von Korff RW, Murphy DL (eds) Monoamine oxidase: Structure, function and altered functions. Academic Press, New York, pp 1–24
4. Davison AN (1957) The mechanism of the irreversible inhibition of rat liver monoamine oxidase by iproniazid (Marsilid). Biochem J 67:316–322
5. Ben Ramadan Z, Dostert P, Tipton KF (1999) Some peculiar aspects of monoamine oxidase inhibition. Neurobiology 7:159–174